Personal profile
Research Strategic Pillar
The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):
Research Strategic Pillar Keywords
- Infectious/ Immunological Health
Fingerprint
Dive into the research topics where Vivian Tat is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 25 Article
-
Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
GBD 2019 Acute and Chronic Care Collaborators, Dec 2025, In: Nature communications. 16, 1, 4235.Research output: Contribution to journal › Article › peer-review
Open Access -
Characterizing temporal and global host innate immune responses against SARS-CoV-1 and -2 infection in pathologically relevant human lung epithelial cells
Tat, V. Y., Drelich, A. K., Huang, P., Khanipov, K., Hsu, J. C., Widen, S. G., Tseng, C. T. K. & Golovko, G., Jan 2025, In: PloS one. 20, 1 January, e0317921.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023
GBD 2023 Vaccine Coverage Collaborators, Jul 19 2025, In: The Lancet. 406, 10500, p. 235-260 26 p.Research output: Contribution to journal › Article › peer-review
Open Access50 Link opens in a new tab Scopus citations -
Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering
Liao, Y., Ma, H., Wang, Z., Wang, S., He, Y., Chang, Y., Zong, H., Tang, H., Wang, L., Ke, Y., Cai, H., Li, P., Tang, J., Chen, H., Drelich, A., Peng, B. H., Hsu, J., Tat, V., Tseng, C. T. K. & Song, J. & 20 others, , Feb 11 2025, In: Proceedings of the National Academy of Sciences of the United States of America. 122, 6, e2406659122.Research output: Contribution to journal › Article › peer-review
Open Access5 Link opens in a new tab Scopus citations -
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations
Westberg, M., Su, Y., Zou, X., Huang, P., Rustagi, A., Garhyan, J., Patel, P. B., Fernandez, D., Wu, Y., Hao, C., Lo, C. W., Karim, M., Ning, L., Beck, A., Saenkham-Huntsinger, P., Tat, V., Drelich, A., Peng, B. H., Einav, S. & Tseng, C. T. K. & 2 others, , Mar 13 2024, In: Science Translational Medicine. 16, 738, p. eadi0979 eadi0979.Research output: Contribution to journal › Article › peer-review
Open Access22 Link opens in a new tab Scopus citations